Literature DB >> 12782279

Tob proteins enhance inhibitory Smad-receptor interactions to repress BMP signaling.

Yutaka Yoshida1, Andreas von Bubnoff, Naoko Ikematsu, Ira L Blitz, Junko K Tsuzuku, Eri H Yoshida, Hisashi Umemori, Kohei Miyazono, Tadashi Yamamoto, Ken W Y Cho.   

Abstract

Tob inhibits bone morphogenetic protein (BMP) signaling by interacting with receptor-regulated Smads in osteoblasts. Here we provide evidence that Tob also interacts with the inhibitory Smads 6 and 7. A yeast two-hybrid screen identified Smad6 as a protein interacting with Tob. Tob co-localizes with Smad6 at the plasma membrane and enhances the interaction between Smad6 and activated BMP type I receptors. Furthermore, we have isolated Xenopus Tob2, and show that it cooperates with Smad6 in inducing secondary axes when expressed in early Xenopus embryos. Finally, Tob and Tob2 cooperate with Smad6 to inhibit endogenous BMP signaling in Xenopus embryonic explants and in cultured mammalian cells. Our results provide both in vitro and in vivo evidence that Tob inhibits endogenous BMP signaling by facilitating inhibitory Smad functions.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12782279     DOI: 10.1016/s0925-4773(03)00020-0

Source DB:  PubMed          Journal:  Mech Dev        ISSN: 0925-4773            Impact factor:   1.882


  19 in total

1.  xBtg-x regulates Wnt/beta-Catenin signaling during early Xenopus development.

Authors:  Oliver Wessely; James I Kim; Uyen Tran; Luis Fuentealba; E M De Robertis
Journal:  Dev Biol       Date:  2005-07-01       Impact factor: 3.582

2.  Genome-wide identification of microRNA targets in human ES cells reveals a role for miR-302 in modulating BMP response.

Authors:  Inna Lipchina; Yechiel Elkabetz; Markus Hafner; Robert Sheridan; Aleksandra Mihailovic; Thomas Tuschl; Chris Sander; Lorenz Studer; Doron Betel
Journal:  Genes Dev       Date:  2011-10-15       Impact factor: 11.361

3.  The role of the TOB1 gene in growth suppression of hepatocellular carcinoma.

Authors:  Sheyu Lin; Qingfeng Zhu; Yang Xu; Hui Liu; Junyu Zhang; Jiawei Xu; Honglian Wang; Qing Sang; Qinghe Xing; Jia Fan
Journal:  Oncol Lett       Date:  2012-08-16       Impact factor: 2.967

4.  Suppression of human lung cancer cell proliferation and metastasis in vitro by the transducer of ErbB-2.1 (TOB1).

Authors:  Yang Jiao; Ke-kang Sun; Lin Zhao; Jia-ying Xu; Li-li Wang; Sai-jun Fan
Journal:  Acta Pharmacol Sin       Date:  2011-12-12       Impact factor: 6.150

5.  Arkadia amplifies TGF-beta superfamily signalling through degradation of Smad7.

Authors:  Daizo Koinuma; Masahiko Shinozaki; Akiyoshi Komuro; Kouichiro Goto; Masao Saitoh; Aki Hanyu; Masahito Ebina; Toshihiro Nukiwa; Keiji Miyazawa; Takeshi Imamura; Kohei Miyazono
Journal:  EMBO J       Date:  2003-12-15       Impact factor: 11.598

6.  Tob1 is a constitutively expressed repressor of liver regeneration.

Authors:  Karen J Ho; Nhue L Do; Hasan H Otu; Martin J Dib; Xianghui Ren; Keiichi Enjyoji; Simon C Robson; Ernest F Terwilliger; Seth J Karp
Journal:  J Exp Med       Date:  2010-05-31       Impact factor: 14.307

7.  Tob2 inhibits peroxisome proliferator-activated receptor γ2 expression by sequestering Smads and C/EBPα during adipocyte differentiation.

Authors:  Akinori Takahashi; Masahiro Morita; Kazumasa Yokoyama; Toru Suzuki; Tadashi Yamamoto
Journal:  Mol Cell Biol       Date:  2012-10-15       Impact factor: 4.272

8.  Structural basis for the antiproliferative activity of the Tob-hCaf1 complex.

Authors:  Masataka Horiuchi; Kosei Takeuchi; Nobuo Noda; Nobuyuki Muroya; Toru Suzuki; Takahisa Nakamura; Junko Kawamura-Tsuzuku; Kiyohiro Takahasi; Tadashi Yamamoto; Fuyuhiko Inagaki
Journal:  J Biol Chem       Date:  2009-03-10       Impact factor: 5.157

Review 9.  Tob, a member of the APRO family, regulates immunological quiescence and tumor suppression.

Authors:  Dimitrios Tzachanis; Vassiliki A Boussiotis
Journal:  Cell Cycle       Date:  2009-04-30       Impact factor: 4.534

10.  Retinoic acid enhances skeletal muscle progenitor formation and bypasses inhibition by bone morphogenetic protein 4 but not dominant negative beta-catenin.

Authors:  Karen A M Kennedy; Tammy Porter; Virja Mehta; Scott D Ryan; Feodor Price; Vian Peshdary; Christina Karamboulas; Josée Savage; Thomas A Drysdale; Shun-Cheng Li; Steffany A L Bennett; Ilona S Skerjanc
Journal:  BMC Biol       Date:  2009-10-08       Impact factor: 7.364

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.